Congress 116 - HR 4710 - Pharmaceutical Independence Long-Term Readiness Reform Act

Sponsor

Cosponsors

Topics

Armed Forces and National Security Buy American requirements Congressional oversight Drug safety, medical device, and laboratory regulation Health technology, devices, supplies Immunology and vaccination Industrial policy and productivity Manufacturing Military medicine Military operations and strategy Military procurement, research, weapons development Military readiness Prescription drugs Public contracts and procurement Strategic materials and reserves Veterans' medical care

Full Text

View Full Bill Text

Votes

Summary

Pharmaceutical Independence Long-Term Readiness Reform Act

This bill generally requires the Department of Defense (DOD) and the Department of Veterans Affairs to only purchase American-made medicines and vaccines. DOD must also (1) report to Congress on medicine supply-chain vulnerabilities, and (2) establish strategies to assure the provision of medicines to enable combat readiness and force health protection.

Actions

Nov 8, 2019

Referred to the Subcommittee on Health.
Oct 17, 2019

Referred to the Committee on Armed Services, and in addition to the Committees on Veterans' Affairs, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 17, 2019

Sponsor introductory remarks on measure. (CR E1297-1298)
Oct 17, 2019

Introduced in House

Amendments

Related Bills